Literature DB >> 24104737

Neurodevice startups target peripheral nervous system.

Michael Eisenstein.   

Abstract

Mesh：

Year:  2013        PMID： 24104737     DOI： 10.1038/nbt1013-865

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  3 in total

1.  Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Authors:  L V Borovikova; S Ivanova; M Zhang; H Yang; G I Botchkina; L R Watkins; H Wang; N Abumrad; J W Eaton; K J Tracey
Journal:  Nature       Date:  2000-05-25       Impact factor: 49.962

2.  Trigeminal nerve stimulation in major depressive disorder: acute outcomes in an open pilot study.

Authors:  Ian A Cook; Lara M Schrader; Christopher M Degiorgio; Patrick R Miller; Eve R Maremont; Andrew F Leuchter
Journal:  Epilepsy Behav       Date:  2013-06-14       Impact factor: 2.937

3.  Randomized controlled trial of trigeminal nerve stimulation for drug-resistant epilepsy.

Authors:  Christopher M DeGiorgio; Jason Soss; Ian A Cook; Daniela Markovic; Jeffrey Gornbein; Diana Murray; Sandra Oviedo; Steven Gordon; Guadalupe Corralle-Leyva; Colin P Kealey; Christi N Heck
Journal:  Neurology       Date:  2013-01-30       Impact factor: 9.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.